Literature DB >> 17483076

Central nervous system involvement of previously undiagnosed chronic lymphocytic leukemia in a patient with neuroborreliosis.

M Kalac1, V Suvic-Krizanic, S Ostojic, I Kardum-Skelin, B Barsic, B Jaksica.   

Abstract

Leukemic involvement of the central nervous system (CNS) in previously undiagnosed chronic lymphocytic leukemia (CLL) is very rare. We report the case of a 62-year-old man with neuroborreliosis in which cytologic, immunocytochemical, and flow cytometry analyses revealed the presence of clonal B-lymphocytes in the cerebrospinal fluid (CSF). After the patient received antimicrobial therapy, his meningeal symptoms cleared up, and the number of cells in the CSF decreased. Monoclonal lymphocytes were still detectable at the same percentage, however, despite systemic chlorambucil therapy. The application of intrathecal dexamethasone therapy led to the disappearance of B-cell CLL (B-CLL) cells in the CSF. We presumed that the neuroborreliosis enabled the transmigration of leukocytes, including B-CLL cells, across the blood-brain barrier via activation of matrix metalloproteinase 9, an enzyme known to open the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17483076     DOI: 10.1532/IJH97.E0618

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  19 in total

1.  Chronic lymphocytic leukaemia with symptomatic diffuse central nervous system infiltration responding to therapy with systemic fludarabine.

Authors:  M A Elliott; L Letendre; C Y Li; J D Hoyer; J E Hammack
Journal:  Br J Haematol       Date:  1999-03       Impact factor: 6.998

2.  Leukemic meningitis in B-cell chronoc lymphocytic leukemia: resolution following intrathecal methotrexate.

Authors:  A M Marmont
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

3.  Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count.

Authors:  M Yushchenko; F Weber; M Mäder; U Schöll; M Maliszewska; H Tumani; K Felgenhauer; W Beuche
Journal:  J Neuroimmunol       Date:  2000-10-02       Impact factor: 3.478

Review 4.  Leukemic leptomeningeal involvement in stage 0 and stage 1 chronic lymphocytic leukemia.

Authors:  W G Brick; M Majmundar; L K Hendricks; A M Kallab; R E Burgess; A P Jillella
Journal:  Leuk Lymphoma       Date:  2002-01

5.  Borrelia burgdorferi, host-derived proteases, and the blood-brain barrier.

Authors:  Dennis J Grab; George Perides; J Stephen Dumler; Kee Jun Kim; Jinho Park; Yuri V Kim; Olga Nikolskaia; Kyoung Seong Choi; Monique F Stins; Kwang Sik Kim
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 6.  Nucleoside analogues in the treatment of haematological malignancies.

Authors:  S A Johnson
Journal:  Expert Opin Pharmacother       Date:  2001-06       Impact factor: 3.889

7.  A woman who couldn't speak: report of methotrexate neurotoxicity.

Authors:  P Szawarski; C S Chapman
Journal:  Postgrad Med J       Date:  2005-03       Impact factor: 2.401

8.  B cell chronic lymphocytic leukemia with meningeal infiltration by T lymphocytes.

Authors:  Anna Remková; Tatiana Bezayová; Milan Vyskocil
Journal:  Eur J Intern Med       Date:  2003-02       Impact factor: 4.487

9.  Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis.

Authors:  R Paul; S Lorenzl; U Koedel; B Sporer; U Vogel; M Frosch; H W Pfister
Journal:  Ann Neurol       Date:  1998-10       Impact factor: 10.422

10.  Physicochemical and pharmacokinetic parameters of seven lipophilic chlorambucil esters designed for brain penetration.

Authors:  N H Greig; S Genka; E M Daly; D J Sweeney; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

View more
  6 in total

1.  Neuroborreliosis and CNS lymphoma: what is the nexus?

Authors:  Carlo Emanuele Saggese; Laura Cecotti; Lucio Giuseppe Lazzarino de Lorenzo
Journal:  Neurol Sci       Date:  2013-08-10       Impact factor: 3.307

2.  Leptomeningeal Carcinomatosis in Chronic Lymphocytic Leukemia: A Case Report and Review of the Literature.

Authors:  Alipi V Naydenov; Lynne P Taylor
Journal:  Oncologist       Date:  2019-03-06

3.  Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review.

Authors:  Alan A Moazzam; Jan Drappatz; Ryan Y Kim; Santosh Kesari
Journal:  J Neurooncol       Date:  2011-07-17       Impact factor: 4.130

4.  Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia.

Authors:  Paolo Strati; Joon H Uhm; Timothy J Kaufmann; Chadi Nabhan; Sameer A Parikh; Curtis A Hanson; Kari G Chaffee; Timothy G Call; Tait D Shanafelt
Journal:  Haematologica       Date:  2016-01-27       Impact factor: 9.941

5.  Chronic Lymphocytic Leukemia Resulting in Hemorrhagic Brain Masses After Sepsis.

Authors:  Aaron M Gusdon; Sung-Min Cho; Yunis Mayasi; Rachna Malani; Hans A Püttgen; Amy Duffield; Javier Bolaños-Meade; Michael Lim
Journal:  Neurohospitalist       Date:  2019-07-02

Review 6.  Leptomeningeal involvement in B-cell chronic lymphocytic leukemia: a case report and review of the literature.

Authors:  Simone Lima de Souza; Fábio Santiago; Marilza de Moura Ribeiro-Carvalho; Adriano Arnóbio; Andréa Ribeiro Soares; Maria Helena Ornellas
Journal:  BMC Res Notes       Date:  2014-09-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.